Ecdysterone and anti-doping rules: WADA Monitoring Program, 2020–2027

A reference page for athletes, coaches and team doctors: what the WADA documents for 2020–2027 say about ecdysterone and turkesterone, and what they do not say. It is not an approval of any product and not advice to take one.

Updated

Checked on 20 November 2026. Where we read a WADA document in a copy published by a sports body rather than on wada-ama.org, the source list says so. The lists are revised every year, so the date matters as much as the text.

Two documents with different jobs

The Prohibited List is an International Standard under the World Anti-Doping Code. WADA must publish it at least once a year (Code, Article 4.1), and each edition takes effect on 1 January. If a listed substance is found in a sample, that is an anti-doping rule violation, and under Article 2.1.1 the athlete answers for it whether or not there was intent or fault.

The Monitoring Program exists under Article 4.5 of the same Code. It covers substances that are not on the Prohibited List but that WADA wants to watch for signs of misuse in sport. Laboratories report the cases in which they detect these substances, and WADA passes aggregate figures to federations and national agencies at least once a year. A monitored substance is not prohibited, and finding it in a sample is not a violation.

Ecdysterone, year by year

Ecdysterone first appeared in the Program for 2020; the 2019 edition did not include it. The entry has not changed since: it stands under anabolic agents and is monitored in and out of competition. All editions are in WADA’s archive.

Year Monitoring Program Prohibited List WADA document
2020 Ecdysterone: anabolic agents, in and out of competition (first year) Not named 2020 Program
2021 Same entry Not named 2021 Program
2022 Same entry Not named 2022 Program
2023 Same entry Not named 2023 Program
2024 Same entry Not named 2024 Program
2025 Same entry Not named 2025 Program
2026 Same entry Not named 2026 Program
2027 Same entry Not named 2027 Program

“Not named” means that we searched the English text of each year’s List for ecdysterone, other ecdysteroids and turkesterone and found none. The Lists are on WADA’s Prohibited List page; next year’s is on the 2027 List page.

Two notes from WADA itself:

  • In its summary of changes for 2020 WADA wrote that ecdysterone was added to assess patterns and prevalence of misuse, and that, although other ecdysteroids exist, most of the data and stakeholder comments concerned ecdysterone.
  • For 2027 WADA removed several narcotics from the Program because enough information had been collected. Ecdysterone stayed. The 2027 List was approved on 10 September 2026 and enters into force on 1 January 2027; until then the 2026 documents apply.

Turkesterone

Turkesterone is not named in any of the eight Monitoring Programs for 2020–2027, nor in the Prohibited Lists for those years. The 2020 note mentioned above is the only place in these documents where other ecdysteroids come up.

National bodies may speak more broadly. USADA’s explainer deals with ecdysteroids as a group and gives turkesterone as an example. An athlete should therefore ask about both compounds, not only the one WADA names.

Why “not on the List” does not mean “permitted”

Some classes are open-ended. Section S1 of the 2027 List prohibits anabolic agents at all times. Its second part, S1.2 (other anabolic agents), gives examples and states that they are not exhaustive; the steroid part, S1.1, extends to substances with a similar chemical structure or similar biological effect. Section S0 covers pharmacological substances that no governmental health authority has approved for human therapeutic use and that the rest of the List does not address. How these clauses apply to a given compound is for anti-doping organisations to decide, not for a manufacturer.

The status is reviewed every year. USADA explains that ecdysteroids are monitored so that WADA can decide whether to add them to the List. The authors of a study funded by WADA and published in 2019 recommended listing ecdysterone under S1.2; WADA has not done so in any edition up to 2027. Research on these compounds in humans is limited and its results are inconsistent.

Nobody approves supplements. UKAD states that neither WADA, nor UKAD, nor any other anti-doping organisation can endorse or approve a supplement, and that extreme caution is needed with any product that presents itself as suitable for athletes. USADA likewise does not evaluate, certify, approve or endorse supplements.

What national anti-doping organisations say

  • USADA (United States). Ecdysteroids are not currently prohibited and have been monitored since 2020. Athletes who use any supplement should know the risks and use only products certified by a third-party programme.
  • NADA (Germany). On 1 October 2019 it announced that ecdysterone had been added to the monitoring programme for 2020 to observe possible misuse in sport. Its general guidance advises against supplements, among other reasons because contaminated and counterfeit products are regularly found, and notes that independent testing reduces the risk without removing it.
  • UKAD (United Kingdom). There is no guarantee that any supplement is free from banned substances. Athletes should assess the need, the risk and the consequences, and use only batch-tested products.

Contaminated and mislabelled supplements

The rule behind this advice is strict liability: the athlete is responsible for whatever is found in the sample, however it got there. UKAD names three ways in which a supplement can lead to a positive test: contamination during manufacturing, inaccurate labelling and counterfeit products. USADA adds that no regulatory body checks the accuracy of a supplement label before sale, and that the medicines database Global DRO, which USADA runs with partner agencies,, leaves supplements out because their labels are unreliable.

This is a risk of the whole product category. Published laboratory analyses of ecdysteroid supplements are summarised in our journal.

Where Ekdiyan stands

  • The label declares 2.5 mg of ecdysterone and 2.5 mg of turkesterone per tablet.
  • Ekdiyan has not been tested for prohibited substances by an anti-doping laboratory.
  • It carries no third-party “tested for sport” certification.
  • No anti-doping organisation has approved it; as shown above, none approves any supplement.

Because ecdysterone is a monitored substance, laboratories may record its presence in a sample and report it to WADA. We make no statement on whether the product is suitable for an athlete who is subject to doping control.

How to check with your own anti-doping organisation

  1. Identify whose rules apply to you: usually those of your national anti-doping organisation and your international federation.
  2. Open the current documents on wada-ama.org and check the year on the cover. In the autumn two editions are online: the one in force and next year’s.
  3. Search for the substance, then read the classes. Try “ecdysterone”, “20-hydroxyecdysone” and “turkesterone”, then read S0 and S1 in full: a search cannot show what an open-ended class covers.
  4. Ask about the substance, not the brand, in writing, and keep the reply. A medicines database such as Global DRO does not cover supplements.
  5. Ask the manufacturer what was tested on the batch you hold. For Ekdiyan, the answer about anti-doping testing is given above.
  6. Talk to your team doctor before you start, not after, and keep the pack with its batch number.
  7. Check again every autumn, when WADA publishes the next List, and in January, when it takes effect.

This page describes published documents. It is not legal or medical advice, and the final word belongs to your anti-doping organisation.

Sources

  1. WADA. Monitoring Program: current edition and archive
  2. WADA. The 2019 Monitoring Program
  3. WADA. The 2020 Monitoring Program
  4. WADA. The 2021 Monitoring Program
  5. WADA. The 2022 Monitoring Program
  6. WADA. The 2023 Monitoring Program
  7. WADA. The 2024 Monitoring Program
  8. WADA. The 2025 Monitoring Program
  9. WADA. The 2026 Monitoring Program
  10. WADA. The 2027 Monitoring Program
  11. WADA. Prohibited List: current edition and archive of earlier editions
  12. WADA. 2027 Prohibited List: publication page
  13. WADA. Prohibited List 2027, full text
  14. WADA. 2020 Prohibited List: Summary of Major Modifications and Explanatory Notes
  15. WADA. 2027 Prohibited List: Summary of Major Modifications and Explanatory Notes
  16. WADA. World Anti-Doping Code 2021, Articles 2.1.1, 4.1 and 4.5
  17. USADA. What Athletes Need to Know about Ecdysteroids
  18. USADA. Supplement Connect
  19. UK Anti-Doping. Managing Supplement Risks
  20. NADA Germany. WADA veröffentlicht Verbotsliste für 2020, 1 October 2019
  21. NADA Germany. Dopingfallen: questions and answers on food supplements
  22. Isenmann E. et al. Ecdysteroids as non-conventional anabolic agent. Archives of Toxicology, 2019; 93: 1807–1816

Food supplement. Not a medicinal product. Not intended to diagnose, treat, cure or prevent any disease. Ajuga turkestanica contains phytoecdysteroids, including ecdysterone and turkesterone. Research in humans is limited and its results are inconsistent. We make no claims about effects on health, performance or body composition.

Cookie settings

Choose what this website may store in your browser.

Necessary

Always on

Your cookie choice and the unsent draft of the request form. Without them the website cannot remember your decision.

Analytics

Google Analytics: which pages are opened and from where, without advertising features. Loaded only if you switch it on.